The Application of Impulse Oscillometry on the Differential Diagnosis of ACOS,Asthma and COPD.

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

To Assess the Utility of Impulse Oscillometry on a Differential Diagnosis among the Patients with ACOS,asthma and COPD over Age 40.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 90
Healthy Volunteers: f
View:

‣ \- 1.1 ACOS:

⁃ Patient is older than 40 years old.

⁃ There are characteristics of bronchial asthma and COPD.

⁃ There is a history of exposure to risk factors.

⁃ Existence of persistent airflow limitation: After the application of bronchodilators, FEV1/FVC\<0.7, and lung function proved reversible exhalation.

⁃ The existence of reversible airflow limitation: Bronchial Dilation Test positive.

• 2Asthma: 1)Patient is older than 40 years old. 2)History of reversible respiratory symptoms. 3) non-smokers. 4)lung function:At least one time proved that the airflow limitation: Bronchial Dilation Test positive.

• previously diagnosed asthma. 1.3COPD:

⁃ Patient is older than 40 years old.

⁃ Complaints about dyspnea, chronic cough or expectoration.

⁃ There is a history of exposure to risk factors.

⁃ Existence of persistent airflow limitation: After the application of bronchodilators, FEV1/FVC\<0.7.

⁃ The existence of irreversible airflow limitation: Bronchial Dilation Test negative.

Locations
Other Locations
China
Shenjing Hospital
RECRUITING
Shenyang
Contact Information
Primary
YIZHUO GAO, Master
gaoyizhuo.sy@hotmail.com
86+18940257523
Backup
HONGBO LIU, Doctor
liuhb@sj-hospital.org
86+18940254125
Time Frame
Start Date: 2017-06-10
Estimated Completion Date: 2023-12-30
Participants
Target number of participants: 100
Treatments
ACOS group
Impulse Oscillometry Bronchial Dilation Test if needed
Asthma group
Impulse Oscillometry Bronchial Dilation Test if needed
COPD group
Impulse Oscillometry Bronchial Dilation Test if needed
Sponsors
Leads: Shengjing Hospital

This content was sourced from clinicaltrials.gov